ω-3 fatty acid supplementation increases anti-inflammatory cytokines and attenuates systemic disease sequelae in experimental pancreatitis

被引:43
作者
Foitzik, T
Eibl, G
Schneider, P
Wenger, FA
Jacobi, CA
Buhr, HJ
机构
[1] Humboldt Univ, Charite, Dept Surg, D-1086 Berlin, Germany
[2] Free Univ Berlin, Dept Surg, Benjamin Franklin Med Ctr, D-1000 Berlin, Germany
关键词
D O I
10.1177/0148607102026006351
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: The cytokines involved in the systemic inflammatory response in acute pancreatitis (AP) comprise lipid mediators (eg, prostanoids, thromboxanes, leukotrienes) generated from arachidonic acid (AA) and eicosapentaenoic acid (EPA). The AA-derived mediators are generated from ω-6-fatty acid (FA) and have strong proinflammatory effects and the EPA-derived mediators generated from ω-3-fatty acid are less active or even exhibit anti-inflammatory effects. Basic parenteral nutrition delivers ω-6-FA and ω-3-FA at a ratio of approximately 7:1. Aim: To investigate whether altering the FA composition by fish oil supplementation (ω-3-FA) affects cytokine production and the parameters reflecting systemic disease severity in experimental AP. Methods: Severe AP was induced in 30 rats by standardized intraductal infusion of bile salt and IV cerulein. Six hours after AP induction, rats were randomized to TPN using commercial solutions with identical amounts of glucose, amino acids, and fat but different FA compositions: group 1 received a soybean-based fat solution without additional fish oil and group 2 was supplemented with 0.2 g/kg per day fish oil. TPN was continued for 2 days. Serum concentrations of IL-6 and IL-10 were measured before and after AP induction and at 24 and 48 hours after starting TPN. Routine cardiorespiratory and renal parameters were monitored to assess the systemic response at the organ level. Results: Animals treated with fish oil had significantly higher IL-10 values (at 24 hours, 63 ± 7 versus 46 ± 3 pg/mL), produced more urine (28 ± 0.9 versus 21 ± 1.6 mL), and had significantly fewer episodes of respiratory dysfunction (defined as a pO2 < 80 mm Hg or pCO2 > 50 mm Hg for > 15 minutes; 29% versus 67%) during the observation period. Conclusions: Altering eicosanoid mediator precursor availability by infusion of ω-3 fatty acid increases anti-inflammatory cytokines in this model of AP. This together with improved renal and respiratory function suggests that the systemic response to pancreatic injury is attenuated.
引用
收藏
页码:351 / 356
页数:6
相关论文
共 41 条
  • [1] [Anonymous], CLIN INTENS CARE, DOI DOI 10.3109/tcic.6.3.112.120
  • [2] Variables that affect assays for plasma cytokines and soluble activation markers
    Aziz, N
    Nishanian, P
    Mitsuyasu, R
    Detels, R
    Fahey, JL
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (01) : 89 - 95
  • [3] Immunonutrition in the critically ill: A systematic review of clinical outcome
    Beale, RJ
    Bryg, DJ
    Bihari, DJ
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (12) : 2799 - 2805
  • [4] Alteration of n-3 fatty acid composition in lung tissue after short-term infusion of fish oil emulsion attenuates inflammatory vascular reaction
    Breil, I
    Koch, T
    Heller, A
    Schlotzer, E
    Grunert, A
    vanAckern, K
    Neuhof, H
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (11) : 1893 - 1902
  • [5] DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303
  • [6] The potential role of therapeutic cytokine manipulation in acute pancreatitis
    Denham, W
    Norman, J
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 1999, 79 (04) : 767 - +
  • [7] Erstad BL, 2000, ANN PHARMACOTHER, V34, P514
  • [8] Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates
    Foitzik, T
    Eibl, G
    Hotz, HG
    Faulhaber, J
    Kirchengast, M
    Buhr, HJ
    [J]. SURGERY, 2000, 128 (03) : 399 - 407
  • [9] Experimental models of acute pancreatitis: are they suitable for evaluating therapy?
    Foitzik, T
    Hotz, HG
    Eibl, G
    Buhr, HJ
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2000, 15 (03) : 127 - 135
  • [10] Foitzik T, 1997, J Gastrointest Surg, V1, P40